Roivant Sciences Ltd.

ROIVNASDAQHealthcare● Active

$28.59

+$0.01(+0.03%)

Market Cap$20.6B

P/E Ratio—

52W High$32.793

52W Low$10.705

Avg Volume5.8M

Open$28.52

Beta1.14

Net Income Financials Revenue

Roivant Sciences Ltd. (ROIV) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

ROIV · net income · updated Jun 8, 2026

Core profitability metrics

ROIV · net income · margin · TTM · CAGR

Net income was −$299.8M for FY2026 (fiscal year ending 2026-03-31), down 74.3% year-over-year. Net profit margin was -3629.2%. Based on available data, Roivant Sciences Ltd. has been profitable since at least 2020.

FY2026 Net Income−$299.8M▼ -74.3% YoY

Trailing 12M (TTM)−$299.8Mtrailing 4 quarters sum

Net Profit Margin< −999%−$299.8M ÷ $8.3M

YoY Change-74.3%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2020

▸ FMP /income-statement · Annual · ROIV net income history · ROIV profit margin

Annual net income data

ROIV · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2026Loss−$299.8M▼ 74.3%-3629.2%$8.3M

FY2025Loss−$172.0M▼ 104.0%-592.0%$29.1M

FY2024$4.35B▲ +531.0%13294.2%$32.7M

FY2023Loss−$1.01B▼ 19.4%-3200.2%$31.5M

FY2022Loss−$845.3M▼ 4.5%-1528.9%$55.3M

Net income vs peers (Healthcare)

ROIV vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Roivant Sciences Ltd.YOU

ROIV

−$299.8M-74.3%-3629.2%

Loss

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Roivant Sciences Ltd. (ROIV) reported net income of −$299.8M for FY2026 (fiscal year ending 2026-03-31), down 74.3% year-over-year. The net profit margin was -3629.2% — meaning the company kept $-36.29 of every dollar of revenue as profit.

Based on available data, Roivant Sciences Ltd. has been profitable since at least 2020. Net income reached a peak of $4.35B in FY2024. Data available for 7 fiscal years.

Roivant Sciences Ltd.'s net profit margin was -3629.2% for FY2026, based on the latest annual results.

Investors sometimes search for "Roivant Sciences Ltd. net worth" — the company's market capitalization is a separate figure from ROIV net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

ROIV net income · 4 questions

Roivant Sciences Ltd. is not currently profitable on an annual basis. The company reported a net loss of $299.8M for FY2026.

is ROIV profitabledoes ROIV make a profitROIV profitabilityROIV profitable company

▸ Source: FMP /income-statement · GAAP · Roivant Sciences Ltd. · Roivant Sciences Ltd. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026